Filing Details
- Accession Number:
- 0001213900-23-002248
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-11 15:42:13
- Reporting Period:
- 2023-01-09
- Accepted Time:
- 2023-01-11 15:42:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1540159 | Edesa Biotech Inc. | EDSA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1702636 | Lumira Capital Investment Management Inc. | 770-141 Adelaide Street West Toronto A6 M5H 3L5 | No | No | Yes | No | |
1778046 | Peter Velden Der Van | 770-141 Adelaide Street West Toronto A6 M5H 3L5 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Share | Disposition | 2023-01-09 | 132,845 | $2.66 | 1,764,583 | No | 4 | S | Indirect | Held by Lumira Capital II, L.P. |
Common Share | Disposition | 2023-01-09 | 12,284 | $2.66 | 163,170 | No | 4 | S | Indirect | Held by Lumira Capital II (International), L.P. |
Common Share | Disposition | 2023-01-10 | 139,450 | $2.63 | 1,625,133 | No | 4 | S | Indirect | Held by Lumira Capital II, L.P. |
Common Share | Disposition | 2023-01-10 | 12,895 | $2.63 | 150,275 | No | 4 | S | Indirect | Held by Lumira Capital II (International), L.P. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | Held by Lumira Capital II, L.P. |
No | 4 | S | Indirect | Held by Lumira Capital II (International), L.P. |
No | 4 | S | Indirect | Held by Lumira Capital II, L.P. |
No | 4 | S | Indirect | Held by Lumira Capital II (International), L.P. |
Footnotes
- This Form 4 is jointly filed by (i) Lumira Capital II, L.P. ("LCII LP"), (ii) Lumira Capital II (International), L.P. ("LCII INT LP"), (iii) Lumira Capital GP, L.P., (iv) Lumira GP Inc. (v) Lumira GP Holdings Co., and (vi) Lumira Capital Investment Management Inc. Lumira Capital GP, L.P. the general partners of which are Lumira GP Inc. and Lumira GP Holdings Co., is the general partner of LCII LP and LCII INT LP, and each of LCII LP and LCII INT LP is managed by Lumira Capital Investment Management Inc. Mr. van der Velden is an executive officer of Lumira GP Inc., Lumira GP Holdings Co., and Lumira Capital Investment Management Inc. Each of Lumira Capital GP, L.P., Lumira GP Inc., Lumira GP Holdings Co., Lumira Capital Investment Management Inc. and Mr. van der Velden may be deemed to beneficially own the shares held by LCII LP and LCII INT LP, but each disclaim beneficial ownership except to the extent of their pecuniary interest therein, if any.